Corvidia Therapeutics
Latest round
- Series B
Last raised
- Apr 2018
Total raised
- $86M
Investors
- 8
About Corvidia Therapeutics
Corvidia Therapeutics, Inc.Corvidia Therapeutics, Inc. specializes in the development of novel therapies targeting cardiovascular diseases. Founded in 2015 and headquartered in Waltham, US, the company has successfully completed 4 deals, including a significant TRADE SALE in June 2020 when Novo Nordisk A/S acquired the company for an upfront payment of USD 725 mn.Corvidia Therapeutics, Inc. offers a range of biopharmaceutical products aimed at treating cardiovascular conditions. The company's lead therapeutic candidates are designed to address unmet needs in cardiovascular care, promoting better health outcomes through innovative treatment solutions tailored to patient requirements.Revenue generation for Corvidia Therapeutics, Inc. primarily arises from strategic partnerships and licensing agreements related to their therapeutic products. The company generates income through upfront payments and potential royalties based on product performance in the market, although specific pricing plans are not publicly disclosed.In light of the recent acquisition by Novo Nordisk A/S, Corvidia Therapeutics, Inc. is poised to leverage additional resources for advancing its product pipeline. The company plans to further develop its therapies for cardiovascular diseases, with a focus on future product launches that have not been specified yet.
Who invested in Corvidia Therapeutics
8 investors across 2 rounds
See all investors in Corvidia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Corvidia Therapeutics
Who invested in Corvidia Therapeutics?
Corvidia Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Corvidia Therapeutics raised?
Corvidia Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Corvidia Therapeutics last raise money?
Corvidia Therapeutics's most recent round on record is a Series B, in Apr 2018.
What does Corvidia Therapeutics do?
Corvidia Therapeutics is a biotechnology company.
Where is Corvidia Therapeutics headquartered?
Corvidia Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Corvidia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Corvidia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Corvidia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.